The Management of the Medullary Thyroid Cancer Patient

 

Related Videos (117)

Caroline S. Kim, MD, examines the oncogenetic profile, classification and pre- and post-operative management of medullary thyroid cancer (MTC), among the rarest of the thyroid cancers. Topics discussed include the management of recurrence and metastases; the time to intervene; the tyrosine kinase inhibitors vandetanib and cabozantinib in metastatic and progressive MTC, respectively; and the hormonal manifestations of MTC.

 

Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®